Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Unpaid sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Veterinary infectious disease diagnostics industry 3600 synopsis, 2018 - 2032
2.2 Business trends
2.2.1 Technology trends
2.2.2 Infection type trends
2.2.3 Animal type trends
2.2.4 Regional trends
Chapter 3 Veterinary Infectious Disease Diagnostics Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of zoonotic diseases
3.3.1.2 Increasing pet adoption for companionship
3.3.1.3 Advancements in the diagnostic devices
3.3.1.4 Increasing veterinary healthcare expenditure
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost associated with veterinary infectious disease diagnostics tests
3.3.2.2 Lack of awareness about various diseases in underdeveloped countries
3.4 Growth potential analysis
3.4.1 By technology
3.4.2 By infection type
3.4.3 By animal type
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6.3 Asia Pacific
3.7 Technology landscape
3.8 Industry ecosystem
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Competitive dashboard, 2022
4.3 Company matrix analysis, 2022
4.4 Competitive analysis of major market players
4.5 Strategic outlook matrix
Chapter 5 Veterinary Infectious Disease Diagnostics Market, By Technology
5.1 Key segment trends
5.2 Clinical chemistry
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Immunodiagnostics
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 ELISA tests
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Lateral flow assays
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4 Others
5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Molecular Diagnostics
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 PCR tests
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Microarray
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.4 Others
5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Hematology
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6 Urinalysis
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7 Others
5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Veterinary Infectious Disease Diagnostics Market, By Infection Type
6.1 Key segment trends
6.2 Viral
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Bacterial
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Parasitic
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Others
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Veterinary Infectious Disease Diagnostics Market, By Animal type
7.1 Key segment trends
7.2 Companion animal
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.2 Dogs
7.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.3 Cats
7.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.4 Horses
7.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.5 Others
7.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Livestock animal
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3.2 Cattle
7.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3.3 Swine
7.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3.4 Poultry
7.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3.5 Sheep & goats
7.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3.6 Others
7.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Veterinary Infectious Disease Diagnostics Market Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Zoetis Inc.
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Service landscape
9.1.4 Strategic outlook
9.1.5 SWOT analysis
9.2 Neogen Corporation
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Service landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Randox Laboratories, Ltd.
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Service landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Service landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Virbac
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Service landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 IDEXX Laboratories, Inc.
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Service landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 DRG INSTRUMENTS GmbH
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Service landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 Chembio Diagnostic Systems, Inc.
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Service landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Eurofins Technologies
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Service landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 NTBIO Diagnostics Inc.
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Service landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
